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ADAR	 	 	 	 	 	 	 Adenosine	deaminase	acting	on	RNA	
cDNA	 	 	 	 	 	 	 Complementary	DNA	
circRNA	 	 	 	 	 	 Circular	RNA	
DNA	 	 	 	 	 	 	 Deoxyribonucleic	acid	
hnRNP	 																																																																				Heterogeneous	nuclear	ribonecleoprotein	
IRES	 	 	 	 	 	 	 Internal	ribosome	entry	site	
mRNA		 	 	 	 	 	 Messenger	RNA	
miRNA	 	 	 	 	 	 MicroRNA	
PCR	 	 	 	 	 	 	 Polymerase	chain	reaction	
RNA	 	 	 	 	 	 	 Ribonucleic	acid	
RNAse	 	 	 	 	 	 Ribonuclease	
RNA-seq	 	 	 	 	 	 RNA-sequencing	
RT-PCR	 	 	 	 	 	 Reverse	transcription-PCR	
snRNA	 	 	 	 	 	 Small	nuclear	RNA	
sRNA	 	 	 	 	 	 	 Small	RNA	
SR	protein	 	 	 	 	 	 Serine	arginine	protein	
tricRNA	 	 	 	 	 	 tRNA	intronic	circular	RNA	
tRNA	 	 	 	 	 	 	 Transfer	RNA	
rRNA	 	 	 	 	 	 	 Ribosomal	RNA	








Advances	in	RNA-seq	shed	light	on	circular	RNAs	Modern	researchers	have	benefitted	greatly	from	advances	in	high-throughput	sequencing	technologies	that	have	allowed	in-depth	characterization	of	cellular	transcriptomes.	This	has	helped	to	reveal	a	multitude	of	actively	transcribed	and	functionally	relevant	RNA	species	that	had	been	previously	underappreciated,	particularly	with	regard	to	non-coding	RNAs.	Advances	in	many	disciplines	have	contributed	to	this	burgeoning	science,	including	powerful	hardware	and	software	development,	along	with	new	and	improved	molecular	biological	methods.	RNA-seq	has	helped	to	determine	that	>	85%	of	the	human	genome	is	in	fact	transcribed	into	RNA,	whereas	only	3%	is	known	to	code	for	protein	(Hangauer,	Vaughn	and	McManus,	2013).	Though	the	exact	percentage	of	the	genome	that	has	function	is	a	matter	of	debate	(Graur,	2017),	the	discovery	and	characterization	of	new	functions	for	RNA	species	continues	at	an	impressive	rate.	Circular	RNAs	(circRNAs)	represent	one	such	type	of	RNA	that	was	mostly	overlooked	until	recently.	Growth in the study of circRNA processing and function has been propelled 
largely by these advances in high-throughput sequencing technology and refined 
bioinformatic pipelines (Jeck et al., 2013; Jeck and Sharpless, 2014). In addition, the use 
of advanced molecular biological protocols, such as treatment using enzymes such as 




CircRNAs in eukaryotes were once thought of as rare molecules resulting from 
aberrant messenger RNA (mRNA) splicing (Coqcuerelle et al., 1993). It has since 
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become clear that circRNA biogenesis in many eukaryotes proceeds through several 
diverse and evolutionarily conserved biochemical pathways (Lasda and Parker, 2014; 
Petkovic and Müller, 2015; Ebbesen et al., 2017; Fischer and Leung, 2017), resulting in 
an abundant class of RNA molecules with a host of proposed functions (Qu et al., 2016; 
Salzman, 2016). CircRNAs have been shown to be remarkably stable in living cells 
(Kjems and Garrett, 1988; Dalgaard and Garrett, 1992; Lu et al., 2015), potentially due to 
their unique structure and lack of free termini on which the exonucleolytic RNA turnover 
machinery relies. Along with being generally abundant (Jeck et al., 2013), circRNAs can 
be differentially expressed in a tissue-dependent manner and can have expression profiles 
that differ from their parental mRNA (Chen, 2016), suggesting regulated expression and 
diversity of function. CircRNAs are enriched in mammalian and Drosophila brains 
(Hansen et al., 2013; Memczak et al., 2013; Salzman et al., 2013; Rybak-Wolf et al., 
2014; Westholm et al., 2014), are positively correlated with aging (Westholm et al., 
2014), and can be associated with disease risk (Burd et al., 2010). The most well known 
example of circular RNA function is their ability to act as molecular “sponges,” 
competing for binding of molecules that affect gene regulation (Figure 1.3). For 
example, the human circular transcript CDR1as/ciRS-7 contains approximately 70 seed 
target sequences for microRNA-7 (miR-7) and associates with exosomal Argonaute 
proteins in vivo in a miR-7 dependent manner (Hansen et al. 2013, Memczak et al. 
2013). CDR1as/ciRS-7 represents a striking example of the controversial “competing 
endogenous RNA” theory, which posits that transcripts can “compete” for binding of 
microRNAs (miRNAs) and other molecules to affect gene expression (Seitz, 2009; 
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Salmena et al., 2011; Tay et al., 2011). This transcript has overlapping expression 
patterns with miR-7 in mouse brains, suggesting a potential in vivo regulatory interaction 
(Hansen et al., 2013; Memczak et al., 2013). Interestingly, either inhibition of miR-7 or 
ectopic expression of CDR1as causes midbrain development defects in zebrafish 
(Memczak et al., 2013), indicating that disruption of this type of regulation could have 
significant consequence. 
  In addition to miRNAs, circRNAs can also bind and sequester proteins (Figure 
1.3). In human, mouse, and Drosophila, the RNA-binding protein Muscleblind (Mbl) has 
been shown to promote circularization of several transcripts, including the second exon 
of the Mbl pre-mRNA itself (Ashwal-Fluss et al., 2014). In all three species, circMbl 
RNA contains conserved Mbl protein binding sites, and pulldown experiments in 
Drosophila S2 cells revealed an in vivo interaction between Mbl protein and circMbl 
(Ashwal-Fluss et al., 2014), suggesting a possible feedback mechanism by which Mbl 
protein and circMbl interact to control splicing of the parent transcript. The relative 
stability of circRNAs could perhaps contribute to a unique cellular role in initiating and 
maintaining these types of regulatory interactions. 
Circular RNAs can also serve as templates for protein translation (Figure 1.4). 
While it has been known for some time that eukaryotic ribosomes could translate protein 
from in vitro synthesized circRNAs (Chen and Sarnow, 1995), until very recently it was 
up for debate as to whether endogenous circRNAs could be translated. Initiation of 
translation in eukaryotes includes recruitment of RNA to an assembling ribosome 
through association with the 7-methylguanosine cap moiety on the transcript’s 5’-end, 
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which is not present in a circRNA. However, some linear transcripts include elements 
such as an internal ribosome entry site (IRES) that can promote cap-independent 
translation by recruiting the small ribosomal subunit to an internal initiator codon. It was 
reported that inclusion of an IRES can enable translation from engineered circRNAs 
(Chen and Sarnow, 1995; Perriman and Ares, 1998; Wang and Wang, 2015). More 
recently, it was shown that circRNAs lacking an IRES can be translated into proteins. 
Some linear mRNAs can be translated in a cap-independent fashion relying on N6-
methyladenosine (m6A) base-modification sites in their 5’- untranslated regions (UTRs) 
(Meyer et al., 2015). CircRNAs harboring even a single m6A site can also be templates 
for translation (Yang et al., 2017). Since m6A is the most common RNA base 
modification (Linder et al., 2015), this could dramatically increase the number of known 
transcripts with protein-coding potential. Furthermore, endogenous eukaryotic circRNAs 
have recently been measured in polysome fractions, detected by ribosome footprinting, 
and circRNA protein products have been detected by mass-spectrometry, suggesting that 
circRNA translation could be widespread in eukaryotes (Legnini et al., 2017; Pamudurti 
et al., 2017; Yang et al., 2017).  
 
Circular RNA biogenesis 
The most common pathway for RNA circularization occurs via a process termed 
“back-splicing.” Back-splicing proceeds via a canonical 2-step transesterification 
reaction, except that a downstream splice donor sequence becomes ligated to an upstream 
splice acceptor site, resulting in a non-canonical alternative splicing event (Figure 1.5). 
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Importantly, back-splicing has been shown to compete with forward splicing of certain 
pre-mRNA transcripts (Ashwal-Fluss et al., 2014; Starke et al., 2015). RNA elements 
that promote juxtaposition of splice sites close to one another in physical space are 
thought to promote back-splicing. For example, back-splicing of circular transcripts is 
associated with the presence of repetitive elements (e.g. Alu repeats in humans or 
different repetitive elements in other species) that flank the circularized region (Jeck et 
al., 2013; Liang and Wilusz, 2014; Kramer et al., 2015). Additionally, back-splicing can 
be facilitated by RNA-binding proteins such as the aforementioned Mbl, QKI (quaking), 
heterogeneous nuclear ribonucleoproteins (hnRNPs) and serine/arginine (SR) proteins 
(Ashwal-Fluss et al., 2014; Conn et al., 2015; Kramer et al., 2015). Back-splicing can 
also be inhibited by the enzyme adenosine deaminase acting on RNA (ADAR). ADAR 
catalyzes adenosine to inosine base modification, resulting in loss of A-T base pairing at 
that residue. This loss of base-pairing can relax the secondary structure formed by long 
inverted repeats flanking a circularized exon in back-splicing, and thereby inhibit 





















































































In metazoa, ligation of the two exonic tRNA halves is thought to be carried out by 
a complex that contains RtcB-like proteins (Popow et al., 2011; Kosmaczewski et al., 
2014). To determine whether RtcB is also important for formation of tricRNAs, we 
carried out RNA interference (RNAi) in vivo. Database analysis identified CG9987 as the 
putative Drosophila RtcB ortholog. Using the GAL4:UAS system (Dietzl et al., 2007), 
ubiquitous expression of dsRNA targeting CG9987 resulted in pupal lethality. Northern 
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blot and RT-PCR analysis of total larval and pupal RNA from these animals revealed a 
significant reduction in tric31905 expression, relative to controls (Figure 2.8). Despite 
the fact that the fruit fly genome contains 10 tRNA:TyrGUA genes (each of which bears an 
intron), expression of mature tRNA:TyrGUA was also reduced following depletion of 
CG9987 (Figure 2.8 B). These results provide strong support for the hypothesis that 
CG9987 is the Drosophila RtcB ortholog, and that this protein is required for proper 


























































Figure	2.5:	RNAse	R	validation	of	tric31905	circularity.	Total larval RNA samples were 
treated with or without RNase R and run on a 10% TBE-urea gel. RNA was imaged using SYBR 
Gold (left panel), whereas tric31905 (right upper panel), U1 and U4 snRNAs (right lower panel) 




















































































































































































































Cloning	pSICHECK-2	luciferase	reporter	for	miR-21	activity	pSICHECK-2	is	a	dual	luciferase	reporter	plasmid.	The following primers were used to 
amplify cDNA from whole flies to generate a PCR product carrying a miR-21 seed site from the 
3’-UTR of PDCD4.	Forward Xho1: 5’-GGCTCTCGAGGGGACTCTGGCAGAG-3’; Reverse 
Not1 :5’-AATGCGGCCGCGATCCCACCAGT-3’. The PCR product was ligated into 
XhoI/NotI linearized pSICHECK-2. 	
Luciferase	assay	
	 HeLa	cells	were	transfected	with	2	ug	of	pSICHECK-2	and	miR-21	sponge	construct	using	Fugene	Reagent.	After	3	days	incubation,	cells	were	treated	using	Promega	Dual	Luciferase	Reporter	Assay	System.	Luminescence	was	measured	using	a	Tecan	M1000	Microplate	reader.		
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Figures	
	
Figure	Appendix	1.1:	Schematic	of	miR-21-responsive	luciferase	reporter	assay	for	
miR-21	sponge	effectiveness.	Luciferase	tagged	with	PDCD4	3’-UTR	should	be	negatively	regulated	by	miR-21,	which	is	upregulated	in	the	HeLa	cell	type.	If	the	sponge	is	effective,	an	increase	in	luminescence	should	be	observed	as	the	sponge	competing	for	miR-21	binding	relieves	this	repression.	
	 	
	 	105	
	
	 	
	 	106	
Figure	Appendix	1.2:	miR-21	is	expressed	after	transient	transfection	in	HeLa	cells.	RT-PCR	confirms	that	the	miR-21	sponge	is	expressed	as	a	circle	with	concatameric	amplification	products	in	transiently	transfected	cells.	TricBroccoli	was	used	as	a	negative	control,	with	GAPDH	as	a	loading	control.	
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Appendix	Figure	1.2:	Luciferase	assay	for	miR-21	sponge	effectiveness.	Untagged	luciferase	(Luc),	tagged	luciferase	with	PDCD4	3’-UTR	and	miR-21	binding	site	(P-luc),	and	miR-21	tricRNA	sponge	(Sponge)	were	transfected	into	HeLa	cells.	After	three	days,	luminescence	was	measured.	
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APPENDIX	2:	SMN	SPLICING	MODULATOR	tricRNA	EXPRESSION	
	
Goals	and	results	I	also	wanted	to	determine	whether	we	could	use	tricRNAs	as	an	antisense	effector	of	splicing.	In	the	disease	spinal	muscular	atrophy	(SMA),	exon	7	of	the	SMN2	gene	is	skipped	during	splicing	leading	to	an	unstable,	truncated	protein	(Cartegni	and	Krainer,	2002),	which	sensitizes	motor	neurons	and	causes	them	to	degenerate	and	can	lead	to	the	onset	of	loss	of	motor	function	and	death.	Antisense	oligonucleotides	(ASOs)	have	been	successfully	used	therapeutically,	which	bind	the	intronic	splice	silencer	ISS-N1	in	the	intron	directly	downstream	of	exon	7	(Figure	Appendix	2.1	A).	This	binding	abrogates	exon-skipping	(Figure	Appendix	2.1	B)	and	allows	translation	of	stable	and	functional	SMN	(Skordis	et	al.,	2003;	Geib	and	Hertel,	2009;	Zhou	et	al.,	2013).	ASOs	are	typically	chemically	modified	to	make	them	more	stable	in	cells	and	thereby	more	effective	in	treatment.	Since	circRNAs	are	relatively	stable	molecules,	we	speculate	that	an	antisense	circRNA	could	be	a	good	therapeutic	agent	in	the	context	of	SMA.	To	determine	if	I	could	express	a	tricRNA	with	the	splice-modifying	potential,	I	designed	a	tricRNA	with	25	bases	of	complementarity	with	ISS-N1,	similar	to	the	ASO	PMO25	(Figure	Appendix	2.2	A),	which	is	an	effective	SMN	therapeutic	oligonucleotide.	I	expressed	this	construct	in	HEK293T	cells	and	verified	circular	RNA	expression	by	RT-PCR,	observing	a	cDNA	concatamer	PCR	product	characteristic	of	RT-PCR	of	circRNAs.	When	expressed	in	
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HEK293T	cells	via	transient	transfection	of	our	tricRNA	construct	did	not	appear	to	shift	splicing	toward	full-length	SMN.	Boosting	expression	of	the	tricRNA	and/or	re-design	of	the	construct	may	be	necessary	to	affect	SMN	splicing.		
Methods	
Cloning	SMN	splice	modifier	tricRNA	expression	vector	The	following	oligos	were	annealed	and	ligated	into	NotI/SacII	linearized	pTricY	(pGEM	or	pAV	backbone):	Top:	5’-ggccgcgagagcactgtacagtaagattcactttcataatgctggcccgactgcatctcgtggccgc-3’;	Bottom:	5’-ggccacgagatgcagtcgggccagcattatgaaagtgaatcttactgtacagtgctctcgc-3’	where	the	sequence	complimentary	to	SMN	intronic	splice	silencer	is	underlined.		
RT-PCR	The	following	divergent	primers	were	used	to	amplify	and	detect	the	SMN	splice	modifier	triRNA:	Fwd:	5’-	tggcccgactgcatctcg-3’;	Rev:	5’-	actgtacagtgctctcgcgg-3’.	The	following	primer	pair	was	used	to	amplify	SMN	and	SMN2	revealing	splicing	ratios:	Ex5	Fwd	(5′-CTA	TCA	TGC	TGG	CTG	CCT-3′)	and	Ex8	Rev	(5′-CTA	CAA	CAC	CCT	TCT	CAC	AG-3′).		
Cell	culture	and	RNA	preparation	All	cells	were	grown	at	37C	with	5%	CO2	in	DMEM	(Gibco)	supplemented	with	10%	fetal	bovine	serum	and	1%	penicillin	and	streptomycin.	One	million	HEK293T	were	plated	
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in	T-25	flasks	and	incubated	at	37C.	After	24	hours,	cells	were	transfected	with	equimolar	amounts	of	either	circBroc	or	SMN	splice	modifier	tricRNA	expression	vector	using	Fugene	HD	transfection	reagent	(Promega	cat#E2311).	After	72	hours,	total	RNA	was	isolated	from	cells	using	Trizol	reagent	(Thermo	Fisher	Scientific	cat#15596026).		 	
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Figures	
Figure	Appendix	2.1:	Use	of	antisense	oligonucleotides	to	alter	SMN	splicing	in	SMA	
model	mice.	(A)	Diagrammatic	representation	of	the	positions	of	AOs	targeting	the	ISS-N1	region.	The	sequence	of	exon	7	is	shown	in	upper	case	and	that	of	intron	7	in	lower	case.	The	sequence	of	ISS-N1	and	the	annealing	sites	for	the	18-mer	ASO-10–27,	20-mer	HSMNEx7D,	and	25-mer	PMO25	are	highlighted.	(B)	A	representative	reverse	transcription-PCR	image	shows	the	effect	of	PMOs	on	SMN2	exon	7	inclusion	in	cultured	SMA	fibroblasts.	Cells	were	treated	at	100	and	500	nM	in	each	PMO	group.	This	figure	was	adapted	(Zhou	et	al.,	2013).	
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Figure	Appendix	2.2:	SMN	splicing	modifier	tricRNA	design.	This	design	includes	a	12	base	pair	stem	loop	and	25	nucleotides	of	complementarity	to	the	SMN	intron	7	intronic	splice	silencer	(ISS).	
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Figure	Appendix	2.3:	RT-PCR	to	detect	SMN	splice	modifier	tricRNAs	and	exon	7	
inclusion	in	spliced	SMN	transcripts	in	cells	transfected	with	SMN	splice	modifier	
tricRNA	construct.	(A)	SMN	splice	modifier	in	either	pAV	or	pGEM	vector	backbone	was	transfected	into	HEK293T	cells	and	tricRNAs	were	detected	by	RT-PCR,	using	tricBroccoli	as	a	negative	control.	(B)	SMN	splice	modifier	in	either	pAV	or	pGEM	vector	backbone	was	transfected	into	HEK293T	cells	and	RT-PCR	was	used	to	determine	ratios	of	products	of	SMN	splicing.,	with	mock	transfected	and	tricBroccoli	transfected	cellular	RNA	input	as	negative	controls.			 	
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